FDA Postmarketing Office To Expand Research; New Deputy Director Is Honig
This article was originally published in The Tan Sheet
Executive Summary
The Center for Drug Evaluation & Research Office of Postmarketing Drug Risk Assessment will seek to increase its research base in its budget proposal for the fiscal year beginning Oct. 1.
You may also be interested in...
Merck Builds Risk Management Into Drug Development; Hires FDA’s Honi
Merck is building risk management into its product development strategy with the hiring of FDA Office of Drug Safety Director Peter Honig, MD
Merck Builds Risk Management Into Drug Development; Hires FDA’s Honi
Merck is building risk management into its product development strategy with the hiring of FDA Office of Drug Safety Director Peter Honig, MD
FDA Senior Scientist Schwetz To Chair Deputy Commissioner Search Cmte.
FDA Senior Advisor for Science Bernard Schwetz, PhD, will serve as acting deputy commissioner as the agency searches for a permanent deputy for the position recently vacated by Michael Friedman, MD.